About this trial
The purpose of this study is to assess the best time to deliver a message to increase physical activity and how often participants will experience a pain episode in the 24 hours following their receipt of a message to increase physical activity.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age greater than or equal to 65 years.
Patients with a history of bladder, breast, cervical, colorectal, endometrial, lung, and prostate cancer diagnosis and treatment.
Fluent in spoken and written English.
Patient has access to smartphone
Disqualifiers
Patient has metastatic disease.
Patient has cancer recurrence.
Trial design
Single group
Treatments tested in this trial
Physical Activity Promotion Intervention
BehavioralThis physical activity promotion intervention is a micro-randomized trial designed to determine the most effective time to send a message to promote physical activity among cancer survivors who experience chronic pain symptoms.
Treatment groups
Trial outcomes
Primary outcomes
ActiGraph accelerometer measured physical activity behaviors (sedentary, light, moderate, vigorous intensity).
Physical activity will be measured using an ActiGraph accelerometer. Data will be aggregated into physical activity estimations (sedentary, light, moderate, vigorous, steps, etc.) using standard methods. Outcome of interest will be probability older cancer survivors are physically active in the 30 minutes following the receipt of a messaging prompt to promote physical activity.
11-point box scale to assess pain on a scale of 0 (no pain) to 10 (worst possible pain).
Pain state will be assessed by response to the pain rating measured by the 11-Point Box Scale in the study app. Participants will receive a smart phone prompt to rate their pain 4 times per day. Outcome of interest will be probability older cancer survivors experience a pain episode in the 24 hours following the receipt of a messaging prompt to increase physical activity.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Medical College of Wisconsin
Lead sponsor
National Cancer Institute (NCI)
Collaborator